Immunogenetic and immunologic studies of differentiated thyroid cancer

F. Juhasz, P. Boros, G. Szegedi, G. Balazs, P. Suranyi, E. Kraszits, V. Stenszky, N. R. Farid

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The authors have studied in detail human leukocyte antigen (HLA) association in 87 Hungarian patients with thyroid epithelial carcinoma. The authors also examined in a small group of patients, five parameters of cell-mediated immunity and related them to HLA as well as to lymphocytic infiltration of the tumor/normal tissue interface. HLA-DR1 was significantly associated with thyroid carcinoma; the strongest association was in patients with follicular histologic features and DR1 homozygotes were not at greater risk for thyroid cancer. The HLA-DR3 was nonsignificantly increased in patients with papillary or mixed histologic features. The HLA-DR1, 3 heterozygotes were highly associated with follicular carcinoma, carried no risk for papillary carcinoma, and an intermediate risk for tumors with mixed histologic features. Because of the small proportion of DR1, 3 heterozygotes in the follicular and mixed histologic group, its predictive value at the population level was low. Better predictive potential was shown for the phenotype DR1 and/or DR3. Neither metastatic disease nor age at diagnosis (<45 years) could be related to HLA phenotypes. Patients in all histologic variants showed some measure of cell-mediated immunity compared to controls. Patients with papillary carcinoma showed an overall better response than those with tumors with follicular or mixed histology. The HLA-DR could not be related to cell-mediated immune response. Patients with papillary carcinoma with a good cell-mediated immune response occurred with much lower infiltration of the tumor boundary with lymphocyte whereas the follicular carcinoma less cell-mediated immunity was associated with dense lymphocytic infiltration, suggesting the biological relevance of lymphocytic infiltration may be different for the two histologic variants.

Original languageEnglish
Pages (from-to)1318-1326
Number of pages9
JournalCancer
Volume63
Issue number7
Publication statusPublished - 1989

Fingerprint

Immunogenetics
HLA Antigens
Thyroid Neoplasms
Papillary Carcinoma
Cellular Immunity
Heterozygote
Neoplasms
Carcinoma
Phenotype
Homozygote
Histology
Lymphocytes
Population

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Juhasz, F., Boros, P., Szegedi, G., Balazs, G., Suranyi, P., Kraszits, E., ... Farid, N. R. (1989). Immunogenetic and immunologic studies of differentiated thyroid cancer. Cancer, 63(7), 1318-1326.

Immunogenetic and immunologic studies of differentiated thyroid cancer. / Juhasz, F.; Boros, P.; Szegedi, G.; Balazs, G.; Suranyi, P.; Kraszits, E.; Stenszky, V.; Farid, N. R.

In: Cancer, Vol. 63, No. 7, 1989, p. 1318-1326.

Research output: Contribution to journalArticle

Juhasz, F, Boros, P, Szegedi, G, Balazs, G, Suranyi, P, Kraszits, E, Stenszky, V & Farid, NR 1989, 'Immunogenetic and immunologic studies of differentiated thyroid cancer', Cancer, vol. 63, no. 7, pp. 1318-1326.
Juhasz F, Boros P, Szegedi G, Balazs G, Suranyi P, Kraszits E et al. Immunogenetic and immunologic studies of differentiated thyroid cancer. Cancer. 1989;63(7):1318-1326.
Juhasz, F. ; Boros, P. ; Szegedi, G. ; Balazs, G. ; Suranyi, P. ; Kraszits, E. ; Stenszky, V. ; Farid, N. R. / Immunogenetic and immunologic studies of differentiated thyroid cancer. In: Cancer. 1989 ; Vol. 63, No. 7. pp. 1318-1326.
@article{711e36044d1e43b3889611851b1b5f52,
title = "Immunogenetic and immunologic studies of differentiated thyroid cancer",
abstract = "The authors have studied in detail human leukocyte antigen (HLA) association in 87 Hungarian patients with thyroid epithelial carcinoma. The authors also examined in a small group of patients, five parameters of cell-mediated immunity and related them to HLA as well as to lymphocytic infiltration of the tumor/normal tissue interface. HLA-DR1 was significantly associated with thyroid carcinoma; the strongest association was in patients with follicular histologic features and DR1 homozygotes were not at greater risk for thyroid cancer. The HLA-DR3 was nonsignificantly increased in patients with papillary or mixed histologic features. The HLA-DR1, 3 heterozygotes were highly associated with follicular carcinoma, carried no risk for papillary carcinoma, and an intermediate risk for tumors with mixed histologic features. Because of the small proportion of DR1, 3 heterozygotes in the follicular and mixed histologic group, its predictive value at the population level was low. Better predictive potential was shown for the phenotype DR1 and/or DR3. Neither metastatic disease nor age at diagnosis (<45 years) could be related to HLA phenotypes. Patients in all histologic variants showed some measure of cell-mediated immunity compared to controls. Patients with papillary carcinoma showed an overall better response than those with tumors with follicular or mixed histology. The HLA-DR could not be related to cell-mediated immune response. Patients with papillary carcinoma with a good cell-mediated immune response occurred with much lower infiltration of the tumor boundary with lymphocyte whereas the follicular carcinoma less cell-mediated immunity was associated with dense lymphocytic infiltration, suggesting the biological relevance of lymphocytic infiltration may be different for the two histologic variants.",
author = "F. Juhasz and P. Boros and G. Szegedi and G. Balazs and P. Suranyi and E. Kraszits and V. Stenszky and Farid, {N. R.}",
year = "1989",
language = "English",
volume = "63",
pages = "1318--1326",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "7",

}

TY - JOUR

T1 - Immunogenetic and immunologic studies of differentiated thyroid cancer

AU - Juhasz, F.

AU - Boros, P.

AU - Szegedi, G.

AU - Balazs, G.

AU - Suranyi, P.

AU - Kraszits, E.

AU - Stenszky, V.

AU - Farid, N. R.

PY - 1989

Y1 - 1989

N2 - The authors have studied in detail human leukocyte antigen (HLA) association in 87 Hungarian patients with thyroid epithelial carcinoma. The authors also examined in a small group of patients, five parameters of cell-mediated immunity and related them to HLA as well as to lymphocytic infiltration of the tumor/normal tissue interface. HLA-DR1 was significantly associated with thyroid carcinoma; the strongest association was in patients with follicular histologic features and DR1 homozygotes were not at greater risk for thyroid cancer. The HLA-DR3 was nonsignificantly increased in patients with papillary or mixed histologic features. The HLA-DR1, 3 heterozygotes were highly associated with follicular carcinoma, carried no risk for papillary carcinoma, and an intermediate risk for tumors with mixed histologic features. Because of the small proportion of DR1, 3 heterozygotes in the follicular and mixed histologic group, its predictive value at the population level was low. Better predictive potential was shown for the phenotype DR1 and/or DR3. Neither metastatic disease nor age at diagnosis (<45 years) could be related to HLA phenotypes. Patients in all histologic variants showed some measure of cell-mediated immunity compared to controls. Patients with papillary carcinoma showed an overall better response than those with tumors with follicular or mixed histology. The HLA-DR could not be related to cell-mediated immune response. Patients with papillary carcinoma with a good cell-mediated immune response occurred with much lower infiltration of the tumor boundary with lymphocyte whereas the follicular carcinoma less cell-mediated immunity was associated with dense lymphocytic infiltration, suggesting the biological relevance of lymphocytic infiltration may be different for the two histologic variants.

AB - The authors have studied in detail human leukocyte antigen (HLA) association in 87 Hungarian patients with thyroid epithelial carcinoma. The authors also examined in a small group of patients, five parameters of cell-mediated immunity and related them to HLA as well as to lymphocytic infiltration of the tumor/normal tissue interface. HLA-DR1 was significantly associated with thyroid carcinoma; the strongest association was in patients with follicular histologic features and DR1 homozygotes were not at greater risk for thyroid cancer. The HLA-DR3 was nonsignificantly increased in patients with papillary or mixed histologic features. The HLA-DR1, 3 heterozygotes were highly associated with follicular carcinoma, carried no risk for papillary carcinoma, and an intermediate risk for tumors with mixed histologic features. Because of the small proportion of DR1, 3 heterozygotes in the follicular and mixed histologic group, its predictive value at the population level was low. Better predictive potential was shown for the phenotype DR1 and/or DR3. Neither metastatic disease nor age at diagnosis (<45 years) could be related to HLA phenotypes. Patients in all histologic variants showed some measure of cell-mediated immunity compared to controls. Patients with papillary carcinoma showed an overall better response than those with tumors with follicular or mixed histology. The HLA-DR could not be related to cell-mediated immune response. Patients with papillary carcinoma with a good cell-mediated immune response occurred with much lower infiltration of the tumor boundary with lymphocyte whereas the follicular carcinoma less cell-mediated immunity was associated with dense lymphocytic infiltration, suggesting the biological relevance of lymphocytic infiltration may be different for the two histologic variants.

UR - http://www.scopus.com/inward/record.url?scp=0024583613&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024583613&partnerID=8YFLogxK

M3 - Article

VL - 63

SP - 1318

EP - 1326

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 7

ER -